Literature DB >> 11724201

Group B streptococcal infections in newborns.

D M Mullaney1.   

Abstract

Group B streptococcus (GBS) is the most common cause of neonatal infection in North America and is associated with morbidity and mortality. Prompt recognition and treatment of the infection is imperative. Diagnostic tests and treatment options vary, without clear research-based recommendations. Future trends should focus on GBS infection as a public health issue, with an emphasis on prevention.

Entities:  

Mesh:

Year:  2001        PMID: 11724201     DOI: 10.1111/j.1552-6909.2001.tb00012.x

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  5 in total

1.  Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures.

Authors:  Melissa B Miller; Sonia L Allen; Mary Ellen Mangum; Anastassia Doutova; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.

Authors:  Toshimi Kimura; Keisuke Sunakawa; Nobuo Matsuura; Hiroaki Kubo; Shigehiko Shimada; Kazuo Yago
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 3.  Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.

Authors:  Kellie Burnside; Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2011-07       Impact factor: 3.165

Review 4.  Understanding the regulation of Group B Streptococcal virulence factors.

Authors:  Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

5.  High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria.

Authors:  Charles John Elikwu; Oyinlola Oduyebo; Folasade Tolulope Ogunsola; Rose Ihuoma Anorlu; Christy Nene Okoromah; Brigitte König
Journal:  Pan Afr Med J       Date:  2016-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.